The impact of influenza epidemics on mortality: introducing a severity index

American Journal of Public Health
L SimonsenL B Schonberger

Abstract

The purpose of this study was to assess the impact of recent influenza epidemics on mortality in the United States and to develop an index for comparing the severity of individual epidemics. A cyclical regression model was applied to weekly national vital statistics from 1972 through 1992 to estimate excesses in pneumonia and influenza mortality and all-cause mortality for each influenza season. Each season was categorized on the basis of increments of 2000 pneumonia and influenza excess deaths, and each of these severity categories was correlated with a range of all-cause excess mortality. Each of the 20 influenza seasons studied was associated with an average of 5600 pneumonia and influenza excess deaths (range, 0-11,800) and 21,300 all-cause excess deaths (range, 0-47,200). Most influenza A(H3N2) seasons fell into severity categories 4 to 6 (23,000-45,000 all-cause excess deaths), whereas most A(H1N1) and B seasons were ranked in categories 1 to 3 (0-23,000 such deaths). From 1972 through 1992, influenza epidemics accounted for a total of 426,000 deaths in the United States, many times more than those associated with recent pandemics. The influenza epidemic severity index was useful for categorizing severity and provided imp...Continue Reading

References

Jun 1, 1987·American Journal of Public Health·K J Lui, A P Kendal
Jul 1, 1974·American Journal of Epidemiology·J Housworth, A D Langmuir
Sep 1, 1982·The Journal of Infectious Diseases·W P GlezenT D Downs
Nov 1, 1982·American Journal of Public Health·K Choi, S B Thacker
Jun 1, 1981·American Journal of Public Health·W H Barker, J P Mullooly
Jan 1, 1981·American Journal of Epidemiology·D W AllingC H Stuart-Harris

❮ Previous
Next ❯

Citations

May 29, 2001·Reviews in Medical Virology·P D Griffiths
Sep 14, 2002·Statistics in Medicine·Andrew S MugglinIslay Gemmell
Oct 30, 2003·Aging Clinical and Experimental Research·Francesco LandiUNKNOWN SILVERNET-HC Study Group
Jun 24, 2011·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·H UphoffA M Hauri
Jun 23, 2009·Medical Microbiology and Immunology·Martin MichaelisJindrich Cinatl
Dec 5, 2003·The American Journal of Emergency Medicine·Paul A SilkaLinda Park Kim
Jan 1, 2004·American Journal of Preventive Medicine·Richard Kent ZimmermanMahlon Raymund
Dec 4, 2003·Lancet·Karl G NicholsonMaria Zambon
Oct 16, 1999·Lancet·N J Cox, K Subbarao
May 5, 2001·Journal of Virological Methods·A M LeVineJ M Stark
Feb 11, 2000·Antiviral Research·J Treanor, A Falsey
Oct 8, 2003·The Journal of Hospital Infection·H C Maltezou, M Drancourt
Dec 13, 2002·Vaccine·Robert Mischler, Ian C Metcalfe
Nov 24, 1999·Vaccine·R Snacken
Jun 29, 2000·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·T G Boyce, G A Poland
Mar 30, 2000·Infectious Disease Clinics of North America·D StamboulianN Cox
Mar 5, 2003·Trends in Molecular Medicine·Stephan LudwigThorsten Wolff
May 1, 2004·Archivos de bronconeumología·A Escribano Montaner, J R de Juanes Pardo
Feb 20, 2007·Epidemiology and Infection·D L SchanzerB T Winchester
Nov 15, 2011·Epidemiology and Infection·L YangC M Wong
Oct 9, 2012·Epidemiology and Infection·F T M FreitasW N Araujo
Sep 13, 2011·Nature Chemical Biology·Miguel A MataBeatriz M A Fontoura
Mar 13, 2003·Kidney International·David T GilbertsonAllan J Collins
Jan 29, 2000·The New England Journal of Medicine·K M NeuzilM R Griffin
Dec 15, 2000·The New England Journal of Medicine·R B Couch
Mar 22, 2001·The New England Journal of Medicine·T A ReichertM Tashiro
Jun 23, 2001·The New England Journal of Medicine·K FukudaN Cox
Dec 27, 2002·The New England Journal of Medicine·Susan S ChiuJ S Malik Peiris
Feb 23, 2012·Proceedings of the National Academy of Sciences of the United States of America·Melissa B PearceTerrence M Tumpey
Jan 18, 2011·Journal of Toxicology and Environmental Health. Part a·Janet M BensonThomas H March
Jul 30, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Eelko HakKristin L Nichol
Jul 30, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Gregory A Poland
Jul 12, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kathleen M NeuzilPatrick Heagerty
Dec 4, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Chit-Ming WongJ S Malik Peiris
Jun 18, 2005·The Journal of Infectious Diseases·Ville T PeltolaJonathan A McCullers

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.